Fisher & Paykel Healthcare Corporation Limited logo

Fisher & Paykel Healthcare releases new OSA Full Face Mask

Operational Update1 May 2019FPHHealthcare

News Release
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)


Fisher & Paykel Healthcare releases new OSA Full Face Mask


Auckland, New Zealand, 2 May 2019 - Fisher & Paykel Healthcare Corporation Limited

announced today the introduction of an innovative new mask for obstructive sleep apnea

(OSA), F&P Vitera

TM

.


F&P Vitera

F&P Vitera is a full face mask featuring a combination of unique technologies designed to

prioritise patient comfort. Key features include an adaptable seal, RollFit™ XT, which rolls

back and forth on a patient’s nose to provide freedom of movement and reduce pressure.

The seal thickness has also been designed to allow for high levels of stability and durability.


The mask incorporates new VentiCool™ technology in the headgear. This custom made

fabric helps to dissipate heat and moisture, providing a comfortable patient experience.

Together with other new design features such as headgear clips, stability bar, grip tabs and

VisiBlue™ highlights, Vitera is an exciting addition to the popular F&P range of OSA masks.


“Vitera is our next generation of mask seal,” said Managing Director and CEO, Lewis

Gradon. “Our unique RollFit system has been re-designed and improved to create a seal

that performs very well and provides a high level of patient comfort. We know that comfort is

one of the key reasons people discontinue their OSA therapy, so creating a mask that puts

patient comfort first and foremost has been central to our design thinking with Vitera.”


Vitera will initially be available in Australia in May followed shortly by Canada, New Zealand

and Europe. It will be available in other regions, including the United States, on receipt of

relevant regulatory clearances.



About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and

systems for use in respiratory care, acute care, surgery and the treatment of obstructive

sleep apnea. The company’s products are sold in over 120 countries worldwide. For more

information about the company, visit our website www.fphcare.com.



Ends


An image of the Vitera mask is set out above. Should you require a high resolution copy

please email investor@fphcare.co.nz

.


Media & Investor Contacts:

Marcus Driller

VP Corporate

marcus.driller@fphcare.co.nz

+64 (0) 27 578 9663

Hayden Brown

Investor Relations Manager

hayden.brown@fphcare.co.nz

+64 (0) 27 807 8073

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.